Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

307
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
307
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dual-engineered chondrocyte-targeting tetrahedral DNA-based nanoparticle for improved delivery of metformin and alleviation in osteoarthritis.

Biomaterials·2026
Same author

The feedback regulation between DREB2C and E3 ligases DEL1/DEL2 for balancing the initial growth and ABA signaling in Arabidopsis.

The New phytologist·2026
Same author

A QuantiFERON<sup>®</sup>-TB Gold Plus-Based Model for Predicting Latent Tuberculosis Infection in Patients with Diabetes.

Infection and drug resistance·2026
Same author

Intracellular logic computing with DNA tetrahedron processors enables precision cancer theranostics.

Signal transduction and targeted therapy·2026
Same author

A photo-responsive, fisetin-functionalized DNA nanocage for programmed therapy to accelerate early-stage wound healing in aged skin.

Biomaterials·2026
Same author

DNA framework-based nanomedicine platform: a triple-function strategy for treating periodontitis via antibacterial, anti-inflammatory, and osteogenesis-promoting activities.

International journal of oral science·2026

Related Experiment Video

Updated: Jun 10, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

Risk factors for multidrug-resistant tuberculosis: a predictive model study.

Lianpeng Wu1,2, Xiaoxiao Cai3, Xiangao Jiang2,4

  • 1Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, The Ding Li Clinical College of Wenzhou Medical University, Wenzhou, China.

Frontiers in Medicine
|October 14, 2024
PubMed
Summary
This summary is machine-generated.

Rural residence, TB retreatment, pulmonary cavities, high uric acid, and low C-reactive protein are key risk factors for multidrug-resistant tuberculosis (MDR-TB) in patients with drug-resistant tuberculosis (DR-TB). A predictive model using these factors shows promising results.

Keywords:
drug-resistant tuberculosismultidrug-resistant tuberculosisnomogram modelpredictive valuerisk factors

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.6K

Related Experiment Videos

Last Updated: Jun 10, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.6K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Medical Diagnostics

Background:

  • Drug-resistant tuberculosis (DR-TB) poses a significant global health challenge.
  • Multidrug-resistant tuberculosis (MDR-TB) represents a more severe and difficult-to-treat form of TB.
  • Identifying risk factors for MDR-TB is crucial for early detection and intervention.

Purpose of the Study:

  • To investigate independent risk factors associated with MDR-TB development in patients already diagnosed with DR-TB.
  • To develop and validate a predictive model for MDR-TB risk stratification.

Main Methods:

  • Retrospective analysis of 715 patients with DR-TB treated between January 2018 and December 2022.
  • Multivariate logistic regression to identify independent risk factors.
  • Construction and validation of a nomogram predictive model.

Main Results:

  • Independent risk factors for MDR-TB included rural residence, TB retreatment, presence of pulmonary cavity, uric acid (UA) ≥ 346 μmol/L, and C-reactive protein (CRP) < 37.3 mg/L.
  • The nomogram model achieved an AUC of 0.758 (training) and 0.775 (validation).
  • The model demonstrated good calibration and clinical utility.

Conclusions:

  • Residence, TB treatment history, pulmonary cavity, UA, and CRP levels are significantly associated with MDR-TB.
  • The developed nomogram model offers a promising tool for predicting MDR-TB risk in DR-TB patients.